J. Douglas Rizzo, MD

Articles by J. Douglas Rizzo, MD

Transplant Registries: Guiding Clinical Decisions and Improving Outcomes

ByMary M. Horowitz, MD, MS,Fausto R. Loberiza, MD, MS,Christopher N. Bredeson, MD, MS,J. Douglas Rizzo, MD,Melodee L. Nugent, MA

May 1st 2001

About 50,000 hematopoietic stem cell transplantations are performed yearly, primarily for malignancies. Use of this therapy increased dramatically over the past 30 years due to its proven and potential efficacy in diverse

Latest Updated Articles

Transplant Registries: Guiding Clinical Decisions and Improving Outcomes
May 1st 2001

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)